Theranos is going on the offense in its feud with the Wall Street Journal, which last week ripped the company’s diagnostics practices apart in a damning exposé. Theranos today published lengthy rebuttal, calling much of the WSJ piece "simply wrong." Is it?
Read Full Article »
